These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2194852)

  • 1. [Effect of pepstatin A on Candida albicans infection in the mouse].
    Zotter C; Haustein UF; Schönborn C; Grimmecke HD; Wand H
    Dermatol Monatsschr; 1990; 176(2-3):189-98. PubMed ID: 2194852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolongation of serum half-life of interleukin 2 and augmentation of lymphokine-activated killer cell activity by pepstatin in mice.
    Ohnishi H; Lin KM; Chu TM
    Cancer Res; 1990 Feb; 50(4):1107-12. PubMed ID: 2297759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of an experimental mouse Candida infection by human dialyzable leukocyte extract.
    Sen P; Smith JK; Buse M; Hsieh HC; Lavenhar MA; Lintz D; Louria DB
    Sabouraudia; 1982 Jun; 20(2):85-93. PubMed ID: 7051369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of leflunomide on gastrointestinal Candida albicans infection induced in naive and arthritic newborn mice.
    Dimitrova P; Ivanovska N
    Int Immunopharmacol; 2006 Nov; 6(11):1682-9. PubMed ID: 16979122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice.
    MacCallum DM; Odds FC
    Mycoses; 2005 May; 48(3):151-61. PubMed ID: 15842329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic infection following intravenous inoculation of mice with Candida albicans int1 mutant strains.
    Bendel CM; Kinneberg KM; Jechorek RP; Gale CA; Erlandsen SL; Hostetter MK; Wells CL
    Mol Genet Metab; 1999 Aug; 67(4):343-51. PubMed ID: 10444345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic candidiasis in mice. I.--Correlation between kidney infection and mortality rate.
    Hurtrel B; Lagrange PH; Michel JC
    Ann Immunol (Paris); 1980; 131C(1):93-104. PubMed ID: 7396418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida albicans--do mycelia matter?
    Ryley JF; Ryley NG
    J Med Vet Mycol; 1990; 28(3):225-39. PubMed ID: 2213438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of farnesol against oral candidiasis in mice.
    Hisajima T; Maruyama N; Tanabe Y; Ishibashi H; Yamada T; Makimura K; Nishiyama Y; Funakoshi K; Oshima H; Abe S
    Microbiol Immunol; 2008 Jul; 52(7):327-33. PubMed ID: 18667031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of aspartic proteases in disseminated Candida albicans infection in mice.
    Fallon K; Bausch K; Noonan J; Huguenel E; Tamburini P
    Infect Immun; 1997 Feb; 65(2):551-6. PubMed ID: 9009312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LAAE-14, a new anti-inflammatory drug, increases the survival of Candida albicans-inoculated mice.
    Lucas R; Villamón E; Payá M; Alves M; del Olmo E; Gozalbo D; Gil ML
    FEMS Immunol Med Microbiol; 2004 Apr; 40(3):239-42. PubMed ID: 15039100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice.
    Tuite A; Elias M; Picard S; Mullick A; Gros P
    Genes Immun; 2005 Dec; 6(8):672-82. PubMed ID: 16079897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary defence mechanism in mice. A comparative role of alveolar macrophages and polymorphonuclear cells against infection with Candida albicans.
    Lal S; Mitsuyama M; Miyata M; Ogata N; Amako K; Nomoto K
    J Clin Lab Immunol; 1986 Mar; 19(3):127-33. PubMed ID: 3519975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
    Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ
    J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis of phagocytic cells induced by Candida albicans and production of IL-10.
    Gasparoto TH; Gaziri LC; Burger E; de Almeida RS; Felipe I
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):219-24. PubMed ID: 15364107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mycolase and amphotericin B on Candida albicans and Candida pseudotropicalis in vitro and in vivo.
    Chalkley LJ; Trinci AP; Pope AM
    Sabouraudia; 1985 Jun; 23(3):147-64. PubMed ID: 3895468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergic effect of grape seed extract with amphotericin B against disseminated candidiasis due to Candida albicans.
    Han Y
    Phytomedicine; 2007 Nov; 14(11):733-8. PubMed ID: 17913484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced resistance against systemic Candida albicans infection in mice treated with C. albicans DNA.
    Dimitrova P; Yordanov M; Danova S; Ivanovska N
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):231-6. PubMed ID: 18507679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.